Product
IPN10200
2 clinical trials
2 indications
Indication
SpasticityIndication
Moderate to Severe Upper Face LinesClinical trial
An Integrated Phase I/II, Multicentre, Double-blind, Randomised, Dysport and Placebo-controlled, Dose Escalation and Dose-finding Study to Evaluate the Safety and Efficacy of IPN10200 in the Treatment of Adult Upper Limb Spasticity.Status: Recruiting, Estimated PCD: 2024-09-30